Researchers reveal how cancer shuts down T cells
New study shows tumor cells eat up methionine, depriving T cells
Articles
A margetuximab agreement for MacroGenics and EVERSANA
MacroGenics and EVERSANA announce approval-dependent agreement to support launch and commercialization of margetuximab
Taking cancer care to the next level
OneOncology and Genentech announce a multi-year partnership to improve clinical trials, boost comprehensive genomic profiling
Merck snaps up OncoImmune for $425M
The acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19
Defeating Venezuelan equine virus with a decoy
A decoy molecule could help to contain outbreaks of Venezuelan equine encephalitis infection
Hitting the 90s
Moderna reports interim efficacy results of 94.5 percent for its COVID-19 vaccine candidate
UCLA Health, Regeneron Genetics Center initiate research collaboration
The partners will conduct whole-exome sequencing on 150,000 patients in a partnership they say will advance personalized medicine
Cloud confidence
TetraScience and Biosero plan to integrate their technologies to offer a centralized option for R&D data to boost research
Patent Docs: What is required for an ANDA applicant to induce infringement?
GlaxoSmithKline LLC v. Teva Pharmaceuticals (Fed. Cir. 2020) addresses what quantum of culpable conduct is required
Science on fast-forward
Many don’t realize how little “settled science” we’ve got, and the last nine months have brought science out front on a new scale
Keeping tabs on infectious disease
A look at our new online venue for infectious diseases as well as upcoming coverage
